Owl Creek Asset Management’s Japer Therapeutics Warrants JSPRW Stock Holding History

Owl Creek Asset Management’s Portfolio JSPRW Stock Details JSPRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-267,189	Closed	-$8.02K	–	204
2022 Q4	$8.02K	Sell	267,189 -107,644	-29%	-$4.73K	﹤0.01%	193
2022 Q3	$22K	Hold	374,833	–	–	﹤0.01%	221
2022 Q2	$34K	Hold	374,833	–	–	﹤0.01%	249
2022 Q1	$97K	Hold	374,833	–	–	﹤0.01%	263
2021 Q4	$551K	Sell	374,833 -297,224	-44%	-$414K	0.04%	187
2021 Q3	$995K	Hold	672,057	–	–	0.04%	146
2021 Q2	$773K	Hold	672,057	–	–	0.04%	156
2021 Q1	$551K	Hold	672,057	–	–	0.02%	159
2020 Q4	$974K	Sell	672,057 -8,443	-1%	-$10.6K	0.04%	79
2020 Q3	$803K	Hold	680,500	–	–	0.05%	62
2020 Q2	$681K	Hold	680,500	–	–	0.05%	52
2020 Q1	$442K	Buy	+680,500	New	+$535K	0.04%	56

Other funds holding JSPRW

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

ICM

Ionic Capital Management New York $690M AUM 70.34% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

HCM

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

Zazove Associates Incline Village, Nevada $1.22B AUM 1.92% 1-Year Est. Return

EPM

Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Owl Creek Asset Management's JSPRW Position: Q1 2023 in Review

Owl Creek Asset Management sold out of Japer Therapeutics Warrants (JSPRW) in Q1 2023, closing a stake of 267,189 shares — an estimated $8.02K sold.

Owl Creek Asset Management first reported a position in JSPRW in Q1 2020 and held it in 12 quarters. The position peaked at $995K in Q3 2021. 10 funds tracked by Wall St. Rank hold JSPRW as of Q1 2023.

Owl Creek Asset Management reported no remaining Japer Therapeutics Warrants position as of Q1 2023 after selling out during the quarter.
Owl Creek Asset Management sold 267,189 Japer Therapeutics Warrants shares in Q1 2023, an estimated $8.02K.
Owl Creek Asset Management first reported a position in Japer Therapeutics Warrants in Q1 2020 and held it in 12 quarters.
Owl Creek Asset Management's Japer Therapeutics Warrants position peaked at $995K in Q3 2021.
10 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q1 2023.

Based on Owl Creek Asset Management's 13F filing for Q1 2023, filed 15 May 2023.